- Home
- SPPP vs BWAY Comparison
SPPP vs BWAY Comparison
Compare SPPP & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- BWAY
- Stock Information
- Founded
- SPPP 2011
- BWAY 2003
- Country
- SPPP Canada
- BWAY Israel
- Employees
- SPPP N/A
- BWAY N/A
- Industry
- SPPP
- BWAY Medical/Dental Instruments
- Sector
- SPPP
- BWAY Health Care
- Exchange
- SPPP NYSE
- BWAY Nasdaq
- Market Cap
- SPPP 172.2M
- BWAY 201.1M
- IPO Year
- SPPP N/A
- BWAY 2019
- Fundamental
- Price
- SPPP $11.94
- BWAY $13.37
- Analyst Decision
- SPPP
- BWAY Strong Buy
- Analyst Count
- SPPP 0
- BWAY 2
- Target Price
- SPPP N/A
- BWAY $14.25
- AVG Volume (30 Days)
- SPPP 183.3K
- BWAY 54.5K
- Earning Date
- SPPP 01-01-0001
- BWAY 08-05-2025
- Dividend Yield
- SPPP N/A
- BWAY N/A
- EPS Growth
- SPPP N/A
- BWAY N/A
- EPS
- SPPP N/A
- BWAY 0.08
- Revenue
- SPPP N/A
- BWAY $43,457,000.00
- Revenue This Year
- SPPP N/A
- BWAY $351.53
- Revenue Next Year
- SPPP N/A
- BWAY $21.84
- P/E Ratio
- SPPP N/A
- BWAY $65.12
- Revenue Growth
- SPPP N/A
- BWAY 26.86
- 52 Week Low
- SPPP $8.55
- BWAY $5.72
- 52 Week High
- SPPP $11.39
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- SPPP 59.78
- BWAY 73.20
- Support Level
- SPPP $11.57
- BWAY $12.60
- Resistance Level
- SPPP $12.46
- BWAY $13.35
- Average True Range (ATR)
- SPPP 0.26
- BWAY 0.49
- MACD
- SPPP -0.01
- BWAY 0.10
- Stochastic Oscillator
- SPPP 58.33
- BWAY 90.77
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.